FDA hits Florida drugmakers with consent decree

Two Florida drug companies--Hill Dermaceuticals and Hill Labs--are now subject to an FDA consent decree prohibiting them from selling adulterated drugs across state lines. The agency went after the companies for "numerous deviations" from good manufacturing practices and for submitting falsified information, FDA said in a statement. Hill makes several topical prescription drugs and turns out two products on contract with Galderma. Release

Suggested Articles

Monday, Bernstein analysts echoed what many were probably thinking about Novo Nordisk’s Rybselsus price: “Finally we can stop talking about it.”

Low interest rates and strong stock valuations are two top reasons why U.S. drugmakers are on the move for deals.

Despite a 45% premium offered to Allergan investors through the AbbVie buyout, one investor is suing to block the deal.